Exir Pharmaceutical (EXIR) Six-Month Profit Rises 4.5-Fold to 34,165 Billion Rials, More Than Twice All of Fiscal 1404
Sahmino Newsroom | 20 November 2026 | 15 hours ago
In its audited standalone income statement for the six months to 31 Shahrivar 1405 (22 September 2026), filed on Codal on 18 November 2026 (27 Aban), Exir Pharmaceutical (EXIR) reported operating revenue of 83,345 billion rials, up 194% from 28,373 billion rials in the same period a year earlier (a restated comparative column). Gross profit grew 290% to 50,338 billion rials and the gross margin rose from 45.5% to 60.4%.
Operating profit was 47,914 billion rials (up 300%) and net profit 34,165 billion rials, against 7,523 billion rials a year earlier. Earnings per share rose from 816 to 3,711 rials. That net profit equals 220% of the full fiscal 1404 profit (15,498 billion rials), and the six-month revenue equals 144% of that year's revenue (57,933 billion rials). Current-year income tax was 10,293 billion rials, finance costs were 3,742 billion rials, and the company's capital is 9,217 billion rials.
Sahmino context
What the prices have done since this story was published, and what Sahmino wrote around it
From Sahmino that week
Dividend payment: POYA
Calendar | 21 NovemberDividend payment: STIZ
Calendar | 21 NovemberThe PLSH Refinery Fund Still Trades 26% Below Its Net Asset Value, a Discount That Has Narrowed Since September (Friday 20 November 2026)
Article | 20 NovemberPrice, Not Tonnage: NALM Sold Less Aluminium Over Seven Months Yet More Than Doubled Its Sales (Thursday 19 November 2026)
Article | 19 November
More from this market
Darupakhsh Factories (DPAK) Lifts Six-Month Net Profit 7.2-Fold to 60,998 Billion Rials at a 66.1% Gross Margin
Stocks | 15 hours agoZahravi Pharmaceutical (DZAH) Lifts Six-Month Net Profit 313% to 6,386 Billion Rials From 1,546 Billion
Stocks | 4 days agoZagros Darou Parsian (ZGDZ) Lifts Six-Month Net Profit 358% to 35,031 Billion Rials as Revenue Rises 3.96-Fold, 2.3 Times All of Fiscal 1404
Stocks | 18 hours agoDarupakhsh Pharmaceutical Raw Materials (TMVD) Books 18,401 Billion Rials of Six-Month Net Profit, Up 248% and 148% of All of Fiscal 1404
Stocks | yesterday
